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Dan I Lubman2,3 and John W Toumbourou1,4Abstract
Background: There is increasing community and government recognition of the magnitude and impact of
adolescent depression. Family based interventions have significant potential to address known risk factors for
adolescent depression and could be an effective way of engaging adolescents in treatment. The evidence for
family based treatments of adolescent depression is not well developed. The objective of this clinical trial is to
determine whether a family based intervention can reduce rates of unipolar depressive disorders in adolescents,
improve family functioning and engage adolescents who are reluctant to access mental health services.
Methods/Design: The Family Options study will determine whether a manualized family based intervention
designed to target both individual and family based factors in adolescent depression (BEST MOOD) will be more
effective in reducing unipolar depressive disorders than an active (standard practice) control condition consisting of
a parenting group using supportive techniques (PAST). The study is a multicenter effectiveness randomized
controlled trial. Both interventions are delivered in group format over eight weekly sessions, of two hours per
session. We will recruit 160 adolescents (12 to 18 years old) and their families, randomized equally to each
treatment condition. Participants will be assessed at baseline, eight weeks and 20 weeks. Assessment of eligibility
and primary outcome will be conducted using the KID-SCID structured clinical interview via adolescent and parent
self-report. Assessments of family mental health, functioning and therapeutic processes will also be conducted. Data
will be analyzed using Multilevel Mixed Modeling accounting for time x treatment effects and random effects for
group and family characteristics. This trial is currently recruiting. Challenges in design and implementation to-date
are discussed. These include diagnosis and differential diagnosis of mental disorders in the context of adolescent
development, non-compliance of adolescents with requirements of assessment, questionnaire completion and
treatment attendance, breaking randomization, and measuring the complexity of change in the context of a
family-based intervention.
Trial registration: Australia and New Zealand Clinical Trials Registry Title: engaging youth with high prevalence
mental health problems using family based interventions; number 12612000398808. Prospectively registered on 10
April 2012.
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There is increasing community and government recogni-
tion of the magnitude and impact of adolescent depression
in Australia and worldwide. The Australian National
Survey of Mental Health and Wellbeing conducted in
2007 suggested that approximately one in four adolescents
experienced a mental disorder in the 12 months prior to
the survey [1]. However, less than one in four of those
attended a professional service during the preceding six
months [2]. The incidence of mental illness in young
people is the highest of any age group. Seventy-five per-
cent of adults suffering from disorders such as substance
use, mood, and anxiety disorders had an onset age before
24 years [3]. During adolescence, it has been estimated
that between four and eight percent of youth meet criteria
for a major depressive disorder in American studies, with
a 20% cumulative incidence rate for depression in com-
munity samples by the age of 18 [4,5]. One of the most
significant concerns in adolescent mental health is the
elevated risk for suicide in adolescents with depression.
Suicide is the second leading cause of death of young
Australians aged 15 to 24 years [6]. Adolescent suicide
victims are approximately six and a half times more likely
to have been struggling with alcohol or drug abuse,
and 27 times more likely to have been suffering from a
major depressive disorder at the time of their death; com-
pared with demographically matched community control
participants [7].
These multifaceted and complex mental health prob-
lems, occurring within a developmental context and
interacting with family factors, means that the traditional
mental health service delivery and intervention models
have limited success. This is compounded by the find-
ings that less than a quarter of youth who have diagnos-
able mental health issues actually receive services [1,2].
In families where conflict and detachment are prevalent,
parents may have a limited capacity to engage youth in
treatments [8], while young people themselves often
have little motivation to attend services [2]. An increas-
ing number of young people currently grow up experien-
cing alcohol or drug use and mental health problems,
resulting in prolonged financial and material dependence
on their parents [9].
Treatments for adolescent depression
The evidence for treatments of adolescent depression is
less well established than for adult populations [8]. A
number of comprehensive reviews and meta-analyses
show that there is limited evidence and the existing find-
ings have not established the efficacy for either pharma-
cological or current psychological therapies for youth
depression, anxiety and comorbid alcohol or drug abuse
[10-12]. A number of psychological therapies have been
supported for use with depression, anxiety and alcoholor drug abuse in adult studies, and have some limited
support for use with adolescents. The most well re-
searched individual therapy for depression and anxiety
are cognitive behavioral therapies (CBT) which are well
supported as a treatment for depression and anxiety in
adults, but the evidence for the efficacy of these treat-
ments with youth is much weaker [8,13-15]. The key
point, however, is that individual treatment models pre-
suppose the willingness of an adolescent to recognize
problems, engage with services and complete treatments,
which is very frequently not the case [16].
Family as a target for intervention
Family-based interventions may prove to be effective for
depressed adolescents, by: (i) enhancing youth engage-
ment, (ii) targeting interactions between family members
and resolving conflict, (iii) increasing support and family
cohesion, (iv) reducing exposure to stressors within the
family, and (v) maintaining adolescents within protective
family environments for a longer period. There is evi-
dence to suggest that depressed youth who are also in
conflicted parent-child relationships are less responsive to
individual treatments [17]. There is also substantive evi-
dence from cohort studies that risk factors for depressive
and anxiety symptoms are predicted by poor parent-child
relationships, high family conflict, poor family attachments
and detachment from family activities [18,19]. Given the
evidence for family influences, researchers have repeatedly
called for the development of prevention and early inter-
vention programs that target family factors including
assisting parents to create a warm and supportive family
environment, appropriate parental monitoring and the use
of authoritative parenting approaches across adolescence
[20]. The other major advantage of family-based interven-
tions is that they allow an avenue by which young people
who are initially reluctant to acknowledge problems or
attend services can be gradually engaged via other family
members attending the service and showing a motivation
for change.
Based on clinical experience and prior feedback from
local services in an Australian context, if a concerned
parent contacts a youth mental health service but the
young person is unwilling to engage in treatment, the
service is often unable to offer a program for the family.
At most, a parent support session or support group may
be offered to parents. In many cases, parents are in-
formed that unless their adolescent is willing to attend,
no service can be offered.
The current randomized controlled trial was designed
to evaluate the capacity of family based interventions to:
i) reduce the depressive symptoms of young people
(12 to 18 years) and improve the mental health of their
parents; ii) engage adolescents reluctant to use mental
health services individually by working therapeutically
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tioning in the context of adolescent depression.
The development of the BEST MOOD intervention
The intervention to be evaluated is known as the Behavior
Exchange Systems Training (BEST MOOD) program and
has been developed over three distinct stages. The original
BEST intervention was initially developed as a multifamily
group education program for parents, to be delivered by a
mental health professional trained in the model [21,22].
The content of the initial BEST program focused on al-
cohol and drug use by adolescents. This version of the
program was shown to reduce parental mental health
symptoms and family stresses [23]. To increase efficacy for
the youth themselves, the second stage of development
(BEST Plus) included siblings who join their parents in
the group for the final four weeks of the eight week pro-
gram. Evaluations showed additional positive changes in
the family system were produced in mental health and
stress symptoms, family cohesion and increases in action
by young people to address their substance use [9,24-26].
The third major development of the intervention model,
the current BEST MOOD intervention, involved further
developing the program as a broader intervention suitable
for adolescents who present with depressive disorders
[27]. The development of BEST MOOD was motivated by
the predominance of adolescent depression in community
referrals to previous evaluations and our discovery of an
increased motivation of depressed adolescents to attend
the final four sessions of BEST Plus. Accordingly, content
was designed specifically to invite the adolescent to attend
parallel sessions with their parents for the final four ses-
sions and for depressed adolescents to benefit therapeutic-
ally from these sessions. The additional content in BEST
MOOD was designed to complement the messages deliv-
ered to parents concerning improved family functioning,
stress regulation, improved communication and resolution
of major life events in the family’s history. This paper
describes the design of an RCT to evaluate BEST MOOD.
Methods/Design
Overview
The study is a multi-center, double-blind, randomized
controlled trial comparing two group interventions: the
BEST MOOD program and a treatment-as-usual support-
ive parenting program known as Parenting Adolescents
Support Training (PAST). Both interventions are for fam-
ilies of youth who present with a unipolar mood disorder,
here defined as major or minor adolescent depression or
dysthymia. In both treatment conditions, families receive
eight sessions of treatment delivered over two hours per
week. The trial will run across several sites in both me-
tropolitan Melbourne and the regional Victorian city of
Geelong. Families will be recruited primarily from theintake service of a large government run mental health
service in the eastern region of Melbourne (Eastern
Health’s Child and Youth Mental Health Service;
CYMHS), but community referrals will also be accepted
from schools and community based health and mental
health services, and via promotion of the study at commu-
nity forums. At the completion of the interventions, face-
to-face interviews will be conducted to better understand
the level of engagement of participants with the treatment
following intake/assessment. The aims of the qualitative
component of the study are to explore the phenomena of
not taking-up treatment, discontinuing treatment after
commencement, completing treatment and benefiting
from treatment, and the perceived influencing factors on
these outcomes.
The primary outcome measure will be rates of remis-
sion of depressive disorder (major, minor, or dysthymia),
according to a structured diagnostic clinical assessment,
utilizing modules from the Structured Clinical Interview
for DSM-IV Childhood Diagnoses KID-SCID; [28]. The
secondary outcome measures will include: adolescent
mental health (parent and self-reported), parent mental
health, the young person’s level of engagement with
mental health services, the parent-child relationship, and
the therapist-client working alliance. Psychologists, so-
cial workers, and postgraduate psychology students who
will be trained and supervised in one of the interven-
tions for an equivalent amount of time, will deliver treat-
ment. Therapists and assessors are blinded to the
content of the alternate intervention, and are blinded to
whether they are delivering the experimental or control
condition in the study.
Aims and hypotheses
The primary aim of the trial is to evaluate the efficacy of
the two interventions as: (a) treatments for youth mental
health problems and (b) as methods of engaging youth
in treatments. The secondary aims will include: (c) to
build capacity and increase service integration across
several service delivery sectors by providing evidence
based intervention programs for youth and their fam-
ilies; (d) to influence national and state government pol-
icy on the use of family based approaches in the field of
youth mental health; and (e) make use of the study part-
nerships for national promotion and dissemination of
family-based treatment models for youth mental health.
The primary study hypothesis is that youth in the
BEST MOOD intervention will demonstrate significantly
greater rates of remission of depressive disorders (major,
minor, or dysthymia), than youth in the PAST interven-
tion. Secondary hypotheses include: (a) that parental and
youth mental health and relationships will improve in
response to both interventions, but significantly more so
in response to BEST MOOD; (b) that greater treatment
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provements in youth mental health outcomes; and (c)
that youth in the BEST MOOD condition will report
greater treatment engagement than youth in the PAST
condition.
Eligibility criteria
Inclusion criteria
Families will be included in the study where there is an
adolescent aged 12 to 18 years who is currently present-
ing with a depressive disorder. Specifically, the young
person must, at the time of assessment, meet the criteria
for either major depressive disorder, minor depressive
disorder, or dysthymic disorder as assessed via current
DSM-IV criteria.
Exclusion criteria
Exclusion criteria for the study are listed in Table 1. Spe-
cifically, in terms of diagnostic exclusions, youth who
currently report any of the following will be excluded:
mania, hypomania, a bipolar disorder, psychosis or
psychotic disorders, an intellectual disability, a pervasive
developmental disorders, drug dependence other than
alcohol, nicotine or cannabis use, or any severe mental
illness currently requiring inpatient treatment. Other
than these listed diagnostic exclusions, other forms of
co-morbidity will be accepted into the study, as long as
a unipolar depressive disorder is the primary presenting
issue (where this is in doubt clinical assessment with the
senior clinical psychologist, CI Andrew Lewis will deter-
mine eligibility). Other exclusions are if the parent/s or
caregiver/s is/are unwilling or unable to attend and par-
ticipate in a group, or if participating family membersTable 1 Exclusion criteria
Individual exclusions
aMania, hypomania, or bipolar disorder
An intellectual disability or a severe mental illness requiring
inpatient treatment or otherwise impairing their ability to
participate in a group program
An inability to understand spoken English
The parents indicate they are unable to participate fully in
the program, including attendance at group sessions one
evening per week for eight weeks and completing all
questionnaires
aPsychosis or psychotic disorders, including drug induced
psychosis
Pervasive developmental disorder, including autism but
not including Asperger’s syndrome
aDrug dependence, with the exception of alcohol,
nicotine or cannabis
Notes: a A history of these criteria does not exclude parents/caregivers from the stuare unwilling or unable to complete the assessment
process (as per Table 1).
Recruitment
The flow of participants from recruitment through to
end of study is shown in Figure 1, as adapted from
CONSORT guidelines. A multifaceted recruitment strat-
egy will be employed to recruit participants. Intake
workers will be co-located with a local youth mental
health service (the Eastern Health Child and Youth
Mental Health Service (CYMHS) Access Team). Schools
and agencies will be provided with information on the
research study (marketed as the Family Options (FO)
program), educated on the signs and symptoms of mood
disorders, and will be asked to refer relevant families to
the program. The research team will also directly market
to the public via media releases, development of a web-
site, utilizing the existing promotion media of part-
nership agencies and group Emails to local service
providers. The research team will also host free educa-
tion seminars for parents on parenting challenging teens,
as a recruitment strategy. This strategy was found to be
an effective recruitment tool in the pilot study [26].
Enrollment into the trial will involve an intake worker
conducting an initial telephone assessment with a parent
or caregiver of the young person. This assessment will
include: family demographic information, a genogram, a
screen for inclusion and exclusion criteria, a the KID-
SCID Mood Episodes Module B as reported by parents,
and information on the young person and parent/s
current mental health status and support services psy-
chotropic medications, recent alcohol and other drug
use and violence within the family, and risk assessmentsFamily exclusions
A current child protection investigation
The young person is unwilling to undertake the minimum
requirements for entry to the study including completion
of the consent form, telephone KID-SCID interview, and the
baseline questionnaire
The young person is currently pregnant
Insufficient address for follow-up or unwillingness to be
followed-up
The young person is currently fully engaged and regularly
attending a treatment service for their mental health
problems which the family considers are adequately
addressing their mental health needs
dy provided they have been asymptomatic/stable for several months.
Screened for eligibility
(n = )
Excluded
Not meeting inclusion criteria (n = )
Declined to participate (n = )
Excluded
Not meeting diagnostic inclusion 
criteria (n = )
Baseline intake 
assessment including 
KID-SCIDs
(n = )
Randomised
(n = )
Allocated to BEST MOOD
(n = )
Allocated to PAST
(n = )
Post intervention assessment
Lost to Follow-up (n = )
Post intervention assessment
Lost to Follow-up (n = )
3 month post intervention 
assessment
Lost to Follow-up (n = )
3 month post intervention 
assessment
Lost to Follow-up (n = )
Analysed (n = ) Analysed (n = )
Figure 1 CONSORT flow diagram of progress through the phases of the Family Options trial.
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deemed eligible for participation in the trial, the intake
worker will then confirm eligibility by administering se-
lected modules of the KID-SCID to the young person.
The selected modules are those for Major Depressive
Disorder, Minor Depressive Disorder, and Dysthymic
Disorder [28]. If the young person meets the inclusion
criteria, the intake worker will then allocate to treatment
condition using the randomized allocation sequence.
Participants will be advised verbally and in writing that
they will be free to withdraw at any stage upon request.
Attempts will be made to assist families to find an alter-
native source of treatment, where possible, should they
choose to withdraw at any stage.
Randomization procedures and methods
Block randomization will be used following the proced-
ure described in Altman and Bland [29]. It is desirable
to have the number of participants allocated to each
treatment condition similar at all times, in order to fill
the treatment groups at approximately equal rates. The
random number sequence will be generated by CI Lewis,
in the following manner. Using blocks of four, there are
only six possible ways of combining treatments A and B.Therefore for each sequence of four eligible families, both
treatment conditions will be allocated twice. Six blocks
will be generated. Using the website www.random.org, a
random number series will be generated using numbers in
the range of 1 to 6. A number will be allocated to each
block. A second random number sequence will be gener-
ated for the allocation of blocks again. Blocks will then be
arranged by going down each column until 200 conditions
are allocated for Melbourne referrals, and a further 60 al-
located for Geelong referrals. Finally a coin will be tossed
where PAST = A and BEST-MOOD = B for heads, or
PAST = B and BEST-MOOD = A for tails.
Sequentially numbered, opaque, sealed envelopes will
be used to store the allocations, kept with the trial man-
ager. Those allocating to treatment condition (intake
workers) will be blinded to the randomization sequence
and the overall study hypotheses.
Planned interventions
Behavior exchange systems training - mood (BEST MOOD)
BEST MOOD is a fully manualized treatment that has been
developed based on family-systems theory. It consists of an
eight-week, professionally-led group program designed to
assist concerned parents to effectively initiate family
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nents of the BEST MOOD program include: mental health
literacy; clarification of roles within the family; clarification
of family goals to reinforce parental vision and leadership;
skills in family communication, positive reinforcement and
boundary setting; encouraging parent/guardian self-care;
stress reduction techniques, encouragement of family con-
nectedness; and family homework tasks related to these
treatment components. The parent/s initially receive four,
two-hour sessions of weekly intervention, after which the
adolescent (12 to 18) and siblings (aged 12 years of age and
over) are invited to also attend with their parents and
complete four additional, two-hour sessions of a multi-
family weekly intervention. During these last four sessions
there are whole group activities, and also activities in
smaller groups of parents and adolescents separately.Parenting Adolescents Support Training (PAST)
The PAST intervention will act as the treatment-as-
usual control condition in this trial. Parents will attend a
professionally facilitated parenting group which uses
supportive counselling techniques. The PAST interven-
tion runs for eight, weekly two-hour sessions. Youth and
siblings (aged 12 and over) are invited to join in the fifth
week. This intervention has been manualized for the
purpose of this study. The content of PAST has been de-
signed to equate with standard practices in currently
available services in Australia, where if any service is of-
fered, it is likely to consist of a parent support group.
The development of this intervention was guided by the
current protocols for the family mental health support
services in Victoria, Australia. The PAST intervention
offers: (a) supportive counselling to assist parents to ar-
ticulate and identify concerns and (b) psycho-education
to increase parents’ knowledge about youth mental
health problems. The main content of the PAST group is
support and the opportunity to share experiences and
ideas as well as receiving contact with a mental health
professional.Assessments and outcome measures
The following measures will be administered to assess
the previously described study hypotheses across three
time points during the trial: enrollment in the trial (T1),
completion of treatment (T2), and three months post-
treatment completion (T3). To maximize the clinical
validity of the outcome evaluations, these assessments
will involve both clinician administered and self-report
measures. These measures have been chosen based on
piloting in previous trials and in terms of minimizing
participant burden while maximizing sensitivity to clin-
ical change across key domains.Screening measures
Demographics
Demographic and clinical information will be collected
from parent(s)/caregiver(s) and youth, including present-
ing problems, mental health history and treatment, fam-
ily structure, and current psychotropic medications.
Youth depressive disorders
The Structured Clinical Interview for DSM-IV Child-
hood Diagnoses (KID-SCID) [28] is a semi-structured
instrument designed to generate childhood Diagnostic and
Statistical Manual of Mental Disorders Fourth Edition
DSM-IV [30] diagnoses for clinical research studies. This
instrument is modeled on the extensively used adult ver-
sion (SCID). The modular nature of the KID-SCID permits
users to select modules relevant to their research. For the
purpose of this trial, modules were selected to enable the
differential diagnosis of major depressive disorder, minor
depressive disorder and dysthymic disorder. The selected
modules were then tailored for use, such that two versions
were created: one for completion with the young person,
and a brief screening version for completion with a parent/
caregiver. The KID-SCID modules will be conducted via
telephone with young people, to determine eligibility and
to assess the primary study hypothesis.
Modules of the KID-SCID selected for use with young
people in this study as follows: Current Major Depres-
sive Episode B1; Current Manic Episode B6; Hypomanic
Episode B10; Dysthymia B14; Mood Disorder Due to a
General Medical Condition B18; Substance Induced
Mood Disorder B20. Modules B6, B10 and B18 and B20
were included as the differential diagnosis of major de-
pressive, minor depressive and dysthymic disorders re-
quires information elicited in the completion of these
modules. On the recommendation of KID-SCID devel-
oper Frederick Matzner, MD, the research team also
used the following modules to the KID-SCID in the
current trial: Past Major Depressive Episode, Past Manic
Episode, Past Hypomanic Episode, and Major Depressive
Disorder E4. These additional modules enable Current
Mood Disorder Differential Diagnosis Module E to be
completed. Mania, Hypomania and Bipolar Episodes and
Disorders were only assessed to the extent that they
could be ruled out for the purpose of accurate differen-
tial diagnosis of the depressive disorders.
Modules from the KID-SCID were also selected to form a
proxy measure of major and minor depressive episodes
or dysthymia for adolescents based on parent report.
This will be conducted with the parent with regard
to their adolescent. Included are: Current Major or
Minor Depressive Episode; Dysthymia - single item;
Mood Disorder Due to a General Medical Condition
B18; Substance Induced Mood Disorder B20. The con-
vergence of diagnosis via this parent proxy version of
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SCID will be assessed as part of the trial.Youth psychotic symptoms
For differential diagnosis, psychosis will be screened
using selected items of the Psychosis-Like Symptoms
Interview PLIKS; [24]. Positive screens will be further
assessed by a senior clinical psychologist to determine if
the participant should be excluded on the basis of meet-
ing diagnostic criteria.Parent, youth and sibling questionnaires
Participating families will also complete a set of ques-
tionnaires at baseline, post-group and at three month
follow-up, in order to assess the secondary study hy-
potheses. Group attending parents/caregivers, the young
person with depression symptoms, and their siblings
aged 12 and over residing in the family home will all be
invited to complete a set of questionnaires, as follows.Youth and sibling mental health
The Strengths and Difficulties Questionnaire (SDQ) con-
sists of 25 items [31]. The questionnaire will be reported
by the parent about the youth with depressive symp-
toms, and the youth and siblings about themselves. The
items load onto five subscales relating to youth mental
health, including emotional symptoms, conduct prob-
lems, hyperactivity/inattention, peer relationship prob-
lems and prosocial behavior. The Short Mood and
Feelings Questionnaire (SMFQ) consists of 13 items,
which are administered to identify depressive symptoms
amongst youth. The SMFQ is based on the 34-item ver-
sion. Higher scores reflect more depressive symptoms
[32]. The questionnaire will be administered to the par-
ents (reporting about youth), youth (self-report), and
siblings (self-report). A considerable amount of research
indicates that the SMFQ and SDQ have good reliability
and validity [33-35]. The Alcohol Use Disorders Identifica-
tion Test (AUDIT) will be administered to identify recent
problem alcohol drinking behavior [36]. The AUDIT has
shown sound psychometric properties in prior research
[37-39]. The Depressive Experiences Questionnaire for
Adolescents (DEQ-A shortened) is a 20-item questionnaire
is designed to assess youth depressive symptoms, and was
developed from the 66-item DEQ for adults [40]. Items
were identified from the DEQ according to their loading
onto the three subscales; self-criticism, dependency and
efficacy [41]. Adequate internal consistency has also been
demonstrated (DEQ-A shortened self-criticism subscale
alpha = 0.65, DEQ-A shortened dependency subscale
alpha = 0.70, DEQ-A shortened efficacy subscale alpha
not reported) [41].Parent mental health
The Depression Anxiety Stress Scales-21 (DASS-21) is a
21-item measure which reflects three subscales including
depressive symptoms (7 items), anxiety symptoms (7 items)
and stress/tension items (7 items) experienced over the pre-
vious week (9), and will be self-reported by parents. The
items from the original 42-item measure, which loaded
most highly onto the subscales, were selected and reflect
those included in the DASS-21 [42]. Comparable conver-
gent validity has been found with other scales designed to
measure depression, anxiety and stress or tension (that is,
Beck Anxiety Inventory (BAI) and DASS-21 Anxiety sub-
scale r = 0.85, Beck Depression Inventory and DASS-21
Depression subscale r = 0.79, BAI and DASS-21 stress/ten-
sion subscale r = 0.70) [43]. Good internal reliability has
also been shown [43].Familial relationships
The Kansas Family Life Satisfaction Scales - modified
(KFLS-M) is a four-item questionnaire based on the ori-
ginal KFLS administered to parents, designed to assess
the parent-perceived level of satisfaction in the relation-
ships with the other family members [26]. The Experi-
ences in Close Relationships - short form (ECR-S) is a
12-item questionnaire designed to measure attachment
styles in adults, particularly avoidant and anxious attach-
ment styles. The measure is based upon the 36-item
Experiences in Close Relationships. In the current study,
it will be used to measure attachment styles of both par-
ents. The BEST Parenting Questionnaire is a purpose
designed, 15-item questionnaire designed to assess par-
enting experiences, comprising of two subscales that sig-
nify emotional dependence on adolescent behavior and
assertive parenting. The items were developed to assess
changes in behaviors emphasized within the BEST pro-
gram curriculum [22].Youth engagement
A 19-item Engagement Questionnaire devised by the re-
search team will be utilized to determine the youth’s use
of mental health services, medication use, and potential
barriers to service use. The items regarding barriers to and
for service use items are responded to on a 7-point scale
where 1 reflects ‘not at all important’ and 7 reflects ‘a very
important factor’. The University of Rhode Island Change
Assessment Scale Readiness to Change Questionnaire-
DELTA Project (URICA-D) is a 12-item scale [44], and will
be administered to youth with items adapted to reflect
youth readiness to change in relation to their depression
instead of in relation to alcohol and other drug problems.
In addition, youth engagement will be assessed via their
attendance or not at the group with their family when
invited.
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The questionnaire will be completed by the youth ex-
periencing depressive symptoms, and with parental con-
sent, their siblings (aged 12 and over) who reside in the
family home. At each of the three time points, youth
completion of a KID-SCID telephone interview and a full
questionnaire will be reimbursed with AU$15 vouchers,
while the siblings will be reimbursed with AU$10
vouchers for each questionnaire completed.
Sample size and power
The trial aims to recruit a total of n = 160 participants.
Based on pilot work and previously conducted clinical tri-
als of family-based interventions compared to treatment-
as-usual conditions, it has been estimated that it is possible
to generate an effect size of d = 0.63 in reduction of mental
health symptoms, which is equivalent to 14% increase in
the odds of remission [45]. Out pilot data also indicates
that treatment type by time interaction is able to produce
up to 50% remission in depression diagnosis, over and
above treatment type. With an alpha of 0.05 and power
level of 0.90 for two-tailed tests, intraclass correlation co-
efficient (ICC) of 0.17 for within therapy group variation
(estimated from our pilot data), and estimated 10% of vari-
ation in the main outcome accounted for by other variables
in the model (treatment arm, time, parental socioeconomic
status), the minimum sample size required equates to n = 57
per treatment arm. Based on pilot studies, an attrition
rate of 20 to 25% is anticipated. Therefore, a minimum
of 80 participants into each of the two treatment condi-
tions will be recruited. Comparisons will be undertaken
between those who drop out and those who are retained
in order to assess for attrition bias.
With respect to our secondary hypotheses, anticipated
final sample size of 114 individuals, will also allow us to
detect small effect size (d = 0.23) for the treatment arm
by time interaction for continuous outcomes, with 90%
power and alpha level of 0.05, assuming ICC of 0.20 for
within-person (between-assessment) and ICC of 0.07
for within therapy group variation (estimated from our
pilot data).
Statistical analysis plan
Repeated measures binomial data will be analyzed over
three time points using a binary logistic regression
within the Generalized Linear Mixed Model (GLMM).
The model will be fitted in STATA (xtmelogit). For any
continuous-scale data we will use a linear mixed model
approach in STATA. For both types of data we will ex-
plore variance-covariance structures for the evaluations
within an individual. Clinical significance and an index
of reliable change will be calculated for each measure
using the criteria of Jacobson and Truax [46]. Findings
will be analyzed in terms of standardized meandifferences and effect sizes achieved will be compared to
existing high quality trials to determine relative efficacy
of this intervention. Multivariable multilevel models will
also explore other covariates on the relationship between
treatment arm and study outcomes, with a view to im-
proving the intervention and specifying its ideal target
population. Data will be stored in a locked cabinet, and
a password protected computer file will contain de-
identified (coded) data. A proportion of the data will be
double-entered, and range checks will be performed for
accuracy checking. Intention-to-treat analysis will be
used with the last observation carried forward as a con-
servative estimate of outcome when data are missing at
follow-up.
In addition, analysis of qualitative data from the tran-
scribed interviews of participants who did not take up
the option of treatment following intake/assessment, dis-
continued treatment, or completed treatment will be
undertaken. Thematic analysis of participants’ accounts
of their experience of the intake/assessment process and
reasons for either engaging with or distancing them-
selves from the treatment offered will be undertaken.
Meanings participants assign to the process will also be
extracted from the data. Analysis of the data relevant to
the phenomena of interest will assist in the identification
of barriers to engagement and change for families.Ethics
The study protocol has been approved by Eastern Health
Human Research Ethics Committee, Victoria, Australia;
and was then approved by Deakin University Human Re-
search Ethics Committee, Victoria, Australia. All partici-
pants sign written consent forms, and are given verbal
and written full informed consent statements, approved
by the ethics committee (see Additional file 1). Details of
any possible risks, benefits and reporting of harms are
included in this explanation, and this occurs at the initial
point of contact with participants (prior to commencing
the assessment). No harms are expected from participa-
tion in this trial. Participants are given contact details
for an external person on the ethics committee for com-
plaints, independent from investigators and the sponsor.
Protocol modifications will be communicated to relevant
parties (for example, investigators, trial participants,
journals, ethics committee) in written form.Discussion
There are many challenges in conducting clinical trials in
adolescent mental health. These include diagnosis and dif-
ferential diagnosis of mental disorders in the context of
adolescent development, non-compliance of adolescents
with requirements of assessment, questionnaire comple-
tion and treatment attendance, breaking randomization,
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a family-based intervention.
To assess the trial outcomes in the most convincing
manner the research team opted to diagnose depression
in adolescents using a structured interview to ensure
that diagnostic criteria are met. This increases demand
on participants and requires extensive training of the as-
sessment team, as well as monitoring of the quality of
such assessments. In the context of adolescent depres-
sion, the use of structured clinical assessments can be
challenging since this is perceived as an onerous task by
adolescents who often are not forthcoming about their
mental health symptoms. Operationalizing outcomes on
the KID-SCID as the primary outcome of the clinical
trial is therefore not without risk; these include chal-
lenges of high attrition and missing data as well as the
challenge of recruiting adolescents willing to undertake
such assessments. To mitigate these risks, we developed a
parent proxy version of the KID-SCID which will be ad-
ministered to a primary caregiver, and we plan to assess its
accuracy compared with the youth report version.
Another notable feature of our early experiences in
setting up this trial has been the relatively high rate of
initial reports of psychotic-like experiences within a co-
hort of depressed adolescents completing the KID-SCID.
Upon further clinical assessment these experiences often
do not meet full criteria for psychotic disorders, and are
often fleeting experiences or experiences which are phe-
nomenologically distinct from psychotic symptoms.
In terms of inclusion and exclusion criteria, the deci-
sion was made to exclude certain mental disorders that
were likely to make participation difficult or render
treatment less effective, for either parents or youth. As
described above, exclusions are generally limited to se-
vere mental disorders and drug dependence to major
forms of substance abuse which would impede participa-
tion in the groups. Therefore we will not exclude youth
or parents who have used alcohol, nicotine or cannabis.
For parents, we accept parents with both common and
severe mental disorders so long as clinical assessment
indicated that the condition is well managed and does
not require inpatient treatment.
Co-morbidity is common in adolescent mental health.
In this study we elected to accept youth with mental dis-
orders with depression on the condition that a depres-
sive disorder is the primary presenting issue. This
presents a clinical challenge in many cases which can be
unraveled by careful clinical assessment of the course
and duration of the various presenting conditions and
considering information provided by the parent or other
professionals. Problems such as eating disorders, sub-
stance misuse and conduct or behavioral problems are
likely to be co-morbid and have not necessarily been ex-
cluded in the current trial.Collecting data from adolescents is a well recognized
challenge and the participant demands within a RCT are
considerable. Added to this challenge is the high rate of
family conflict, characteristic of adolescent mental health
conditions, operating as a bidirectional influence that is
both a contributing cause and consequence of adoles-
cent mood disorders. We have encountered many cir-
cumstances in a previous trial [24,25] in which parents
are unable to convince adolescents even to provide con-
sent or undertaken a minimal amount of assessment in
order to participate in the trial. The current trial has
sought to address this issue with the use of strategic in-
centives, a staged assessment process and the use of par-
ent proxy reports on adolescents wherever possible.
In terms of study design, we have been mindful of the
challenges inherent in randomizing to treatments that
use different modalities. One of the challenges in the
field of adolescent mental health mentioned in the intro-
duction is that the bulk of the existing evidence is based
on individual adolescent psychological therapies, primar-
ily CBT. In our previous attempt to conduct a head-to-
head comparative trial of CBT versus BEST Plus, we
found that parents randomized to the CBT condition
whose adolescents refused to attend were strongly in-
clined to break the randomization and seek attendance
to the BEST Plus condition. To address that issue, in
this trial we offered equivalent group interventions for
parents. While this has improved the problems of break-
ing randomization, it has also resulted in challenges in
terms of obtaining adequate numbers to commence
groups as scheduled.
Finally, the current trial of a family based intervention is
based on a systemic model of therapeutic change. The
measurement of outcomes needs to consider changes both
in parents and in adolescents, and in terms of overall fam-
ily dynamics. This is a more complex set of outcomes than
one would find in a trial of an individual psychological
therapy and is reflected in the set of measures of both out-
comes and processes chosen in the trial.
Trial status
The trial is currently underway with participants cur-
rently being recruited and assessed. Date of first enrol-
ment is 17 October, 2012. Estimated completion date is
late 2014.
Additional file
Additional file 1: Participant Information and Consent Forms.
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